Patent Assignment
Reel/Frame 030611/0712
Assignment of Assignor's Interest
Recorded: 2013-06-14
Pages: 4
Assignor
FRONTIER BIOTECHNOLOGIES CO., LTD.
Executed: 2013-05-29
Assignee
BAOBAB PHARMACEUTICALS LIMITED
SUN HUNG KAI CENTRE, 30 HARBOUR ROAD, ROOM 1021, WANCHAI, HONG KONG
Covered Properties
(2)
Human Immunodeficiency Virus (Hiv) GP41 Peptide Derivatives with Enhanced Solubility and Antiviral Activity.
Method of Inhibiting Hiv-1 Replication by Administering Modified GP41 C34 Peptide Derivatives with Enhanced Pharmacological Properties
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 29, 2004
From: XIE, DONG; JIANG, HE
To: FRONTIER BIOTECHNOLOGIES CO., LTD.
Reel/Frame 015516/0286 →
Assignment of Assignor's Interest
Oct 25, 2013
From: BAOBAB PHARMACEUTICALS LIMITED
To: NANJING FRONTIER BIOTECHNOLOGIES CO., LTD.
Reel/Frame 031475/0613 →
Change of Name
May 16, 2019
From: NANJING FRONTIER BIOTECHNOLOGIES CO., LTD.
To: FRONTIER BIOTECHNOLOGIES INC.
Reel/Frame 049195/0001 →